These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34540037)

  • 41. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
    Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
    J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
    Kamiya Y; Fujisawa T; Kono M; Nakamura H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Sumikawa H; Johkoh T; Yasui H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Med; 2019 Nov; 159():105811. PubMed ID: 31710871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients.
    Hu Y; Wang LS; Jin YP; Du SS; Du YK; He X; Weng D; Zhou Y; Li QH; Shen L; Zhang F; Su YL; Sun XL; Ding JJ; Zhang WH; Cai HR; Dai HP; Dai JH; Li HP
    Clin Respir J; 2017 May; 11(3):337-345. PubMed ID: 26077281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach.
    Conticini E; d'Alessandro M; Bergantini L; Castillo D; Cameli P; Frediani B; Cantarini L; Bargagli E
    Biology (Basel); 2022 Jan; 11(1):. PubMed ID: 35053092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nintedanib combined with immunosuppressive agents improves forced vital capacity in connective tissue disease-associated PF-ILD: a single-center study.
    Ushio Y; Wakiya R; Kameda T; Nakashima S; Shimada H; Miyagi T; Sugihara K; Mino R; Mizusaki M; Chujo K; Kagawa R; Yamaguchi H; Kadowaki N; Dobashi H
    BMC Rheumatol; 2024 Jun; 8(1):27. PubMed ID: 38886779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.
    Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
    Gen Thorac Cardiovasc Surg; 2016 Nov; 64(11):657-661. PubMed ID: 27515028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis.
    Hong M; Yin X; Yan W; Guo W; Liu H; Yang H
    Biomol Biomed; 2024 Sep; 24(5):1105-1116. PubMed ID: 38743787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease.
    Fu H; Zheng Z; Zhang Z; Yang Y; Cui J; Wang Z; Xue J; Chi S; Cao M; Chen J
    Clin Rheumatol; 2023 Jul; 42(7):1917-1929. PubMed ID: 36929316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Forensic application of three interstitial pneumonia markers: search for new pneumonia markers in dead bodies.
    Okaba K; Inokuchi G; Horioka K; Iwase H; Inoue H; Motomura A; Ishii N; Moue C; Shiomi T; Yajima D
    Int J Legal Med; 2024 Jul; 138(4):1583-1592. PubMed ID: 38379061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
    Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
    Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis.
    Zhang T; Shen P; Duan C; Gao L
    Front Immunol; 2021; 12():745233. PubMed ID: 34956179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
    Shirai Y; Fukue R; Kaneko Y; Kuwana M
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
    Hu C; Wu C; Yang E; Huang H; Xu D; Hou Y; Zhao J; Li M; Xu Z; Zeng X; Wang Q
    Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Serum Biomarkers With Pulmonary Involvement of Rheumatoid Arthritis Interstitial Lung Disease: From KORAIL Cohort Baseline Data.
    Moon J; Lee JS; Yoon YI; Chang SH; Lee YA; Ha YJ; Kang EH; Park YB; Lee H; Choe JY; Lee EY;
    J Rheum Dis; 2021 Oct; 28(4):234-241. PubMed ID: 37476358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between CT Score and KL-6: A Severity Assessing in Juvenile Dermatomyositis Associated Interstitial Lung Disease.
    Wang C; Hou J; Lai J; Tao R; Yang Y; Hao W; Yuan X; Yan Y
    Can Respir J; 2023; 2023():5607473. PubMed ID: 37020746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Krebs von den Lungen-6 levels in untreated idiopathic pulmonary fibrosis.
    Jiang D; Xiao H; Dong R; Geng J; Xie B; Ren Y; Dai H
    Clin Respir J; 2022 Mar; 16(3):234-243. PubMed ID: 35081277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neutrophil extracellular traps-induced endothelial cell damage in the pathogenesis of dermatomyositis-associated interstitial lung disease].
    Zhang Y; Yan B; Liu Y
    Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):650-654. PubMed ID: 28870032
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical Research on Prognostic Evaluation of Subjects With IPF by Peripheral Blood Biomarkers, Quantitative Imaging Characteristics and Pulmonary Function Parameters.
    Guo L; Yang Y; Liu F; Jiang C; Yang Y; Pu H; Li W; Zhong Z
    Arch Bronconeumol (Engl Ed); 2020 Jun; 56(6):365-372. PubMed ID: 31740085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.